dc.creator | Pliaka, V. | en |
dc.creator | Ruether, I. G. A. | en |
dc.creator | Kyriakopoulou, Z. | en |
dc.creator | Kioussi, P. | en |
dc.creator | Plakokefalos, E. | en |
dc.creator | Megalou, M. | en |
dc.creator | Pratti, A. | en |
dc.creator | Levidiotou-Stefanou, S. | en |
dc.creator | Markoulatos, P. | en |
dc.date.accessioned | 2015-11-23T10:45:48Z | |
dc.date.available | 2015-11-23T10:45:48Z | |
dc.date.issued | 2010 | |
dc.identifier | 10.1111/j.1469-0691.2010.03188.x | |
dc.identifier.issn | 1198-743X | |
dc.identifier.uri | http://hdl.handle.net/11615/32344 | |
dc.description.abstract | P>In this study, the serological status of the southern Greek population in the 1-10-year, 11-20-year, 21-30-year and 31-40 -year age groups with regard to Sabin vaccine strains and a collection of 15 recombinant and four non-recombinant poliovirus vaccine strains was determined. For all three poliovirus types, the highest neutralization test (NT) titres were observed in the 1-10-year age group, indicating a good response to vaccination. In general, the serological status of the population of southern Greece with regard to poliovirus is better for types 1 and 2 than for type 3. The presence of the lowest NT titre in the 21-30-year age group against poliovirus type 3 suggests the need for a booster dose of monovalent Sabin3 vaccine to ensure personal and herd immunity. | en |
dc.source | Clinical Microbiology and Infection | en |
dc.source.uri | <Go to ISI>://WOS:000282819000014 | |
dc.subject | Greece | en |
dc.subject | immunity | en |
dc.subject | OPV derivatives | en |
dc.subject | Polioviruses | en |
dc.subject | NORTHERN GREECE | en |
dc.subject | POLIOMYELITIS | en |
dc.subject | STRATEGY | en |
dc.subject | Infectious Diseases | en |
dc.subject | Microbiology | en |
dc.title | A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece | en |
dc.type | journalArticle | en |